The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice.
High density lipoprotein (HDL) cholesterol levels are inversely related to cardiovascular disease risk and associated with a reduced risk of type 2 diabetes. Apolipoprotein A-I (apoA-I; major HDL protein) mimetics have been reported to reduce atherosclerosis and decrease adiposity. This study invest...
Main Authors: | Michelle M Averill, Eung Ju Kim, Leela Goodspeed, Shari Wang, Savitha Subramanian, Laura J Den Hartigh, Chongren Tang, Yilei Ding, Catherine A Reardon, Godfrey S Getz, Alan Chait |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4186861?pdf=render |
Similar Items
-
Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr−/− Mice
by: Savitha Subramanian, et al.
Published: (2018-02-01) -
Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis
by: Getz GS, et al.
Published: (2011-06-01) -
Deletion of serum amyloid A3 improves high fat high sucrose diet-induced adipose tissue inflammation and hyperlipidemia in female mice.
by: Laura J den Hartigh, et al.
Published: (2014-01-01) -
Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties
by: Geoffrey D. Wool, et al.
Published: (2008-06-01) -
Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice
by: Savitha Subramanian, et al.
Published: (2013-10-01)